Stay updated on M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page.

Latest updates to the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe NCT03620201 record now presents details of the completed Phase 1 M7824 breast cancer study, including its design, eligibility criteria, outcomes, and enrollment dates. It also includes investigator and sponsor information, locations, and an informed consent document.SummaryDifference45%

- Check15 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner was added announcing NIH website changes and explaining the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision marker changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating the study record is not accessible and the site presents a blocked-access page.SummaryDifference18%

Stay in the know with updates to M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 for Stage II-III HER2+ Breast Cancer Clinical Trial page.